Pfizer files US court challenge to Novo's bid for Metsera
MLex Summary: Pfizer filed a US complaint against Novo Nordisk, Metsera, and three investment funds to enjoin Novo’s competing bid for Metsera, calling it “one of the most cynical and anticompetitive...To view the full article, register now.
Already a subscriber? Click here to view full article